Chardan Capital Reaffirms Buy Rating for Oculis (NASDAQ:OCS)
Oculis (NASDAQ:OCS – Get Free Report)‘s stock had its “buy” rating restated by Chardan Capital in a note issued to investors on Thursday,Benzinga reports. They presently have a $28.00 price target on the stock. Chardan Capital’s price target points to a potential upside of 49.17% from the company’s current price. Separately, HC Wainwright reduced their […]
Oculis (NASDAQ:OCS – Get Free Report)‘s stock had its “buy” rating restated by Chardan Capital in a note issued to investors on Thursday,Benzinga reports. They presently have a $28.00 price target on the stock. Chardan Capital’s price target points to a potential upside of 49.17% from the company’s current price. Separately, HC Wainwright reduced their […]
